Events

ARCHITECT ® anti-HBs reagents 의 리콜

L’Agence nationale de sécurité du médicament et des produits de santé (ANSM)에 따르면, 해당 리콜 는 France 에서 ABBOTT DIAGNOSTIC 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 날짜
    2004-09-14
  • 사례 국가
    France
  • 사례 출처
    ANSM
  • 사례 출처 URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retraits-de-lots-du-dmdiv-architect-reactifs-anti-hbs-de-par-abbott-diagnostics
  • 비고 / 경고
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • 데이터 추가 비고
  • 조치
    On September 13, 2004, Abbott Diagnostics withdrew from the market. lots 17048M100 (per.07.04.05); 10014M200 (per.05.01.05); 09140M300 (per.17.10.04) and 08672M200 (per.16.10.04) of the reference 7C18-20. the lot 10014M201 (per.05.01.05) of the reference 7C18-2. and batches 13251M100 (per.01.06.05) and 10015M200 (per.06.01.05) of reference 7C18-3. of the in vitro diagnostic medical device called ARCHITECT ® anti-HBs reagents, following the detection of a stability problem that could lead to calibration failures, to non-standard quality control values ​​and sometimes to non-standard results. Discordant patients. This device allows the assay of anti-HBs antibodies (antibodies against hepatitis B virus surface antigen) in human serum or plasma, on the ARCHITECT automaton.

Device

ARCHITECT ® anti-HBs reagents
  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    in-vitro_medical_device
  • Manufacturer
    ABBOTT DIAGNOSTIC

Manufacturer

ABBOTT DIAGNOSTIC
  • 제조사 모회사 (2017)
    Abbott Laboratories
  • 제조사 의견
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    LAANSM